Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (12): 1203-1206.DOI: 10.3969/j.issn.1673-8640.2020.12.001
MEI Zhaoling1, ZHOU Wenhui2, FENG Jing2()
Received:
2020-10-13
Online:
2020-12-30
Published:
2020-12-31
CLC Number:
MEI Zhaoling, ZHOU Wenhui, FENG Jing. The Progress of Exosomes Application in Diagnosis and Treatmeat of breast cancer[J]. Laboratory Medicine, 2020, 35(12): 1203-1206.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.12.001
[1] | SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2020[J]. CA Cancer J Clin,2020,70(1):7-30. |
[2] | PONDÉ N F,ZARDAVAS D,PICCART M.Progress in adjuvant systemic therapy for breast cancer[J]. Nat Rev Clin Oncol,2019,16(1):27-44. |
[3] | KOWAL J,ARRAS G,COLOMBO M,et al.Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes[J]. Proc Natl Acad Sci U S A,2016,113(8):E968-E977. |
[4] | YANG C,ROBBINS P D.The roles of tumor-derived exosomes in cancer pathogenesis[J]. Clin Dev Immunol,2011,2011:842849. |
[5] | ZHANG Y,LIU Y,LIU H,et al.Exosomes:biogenesis,biologic function and clinical potential[J]. Cell Biosci,2019,9:19. |
[6] | LOWRY M C,GALLAGHER W M,O'DRISCOLL L. The role of exosomes in breast cancer[J]. Clin Chem,2015,61(12):1457-1465. |
[7] | CHAPUT N,SCHARTZ N E,ANDRÉ F,et al.Exosomes as potent cell-free peptide-based vaccine. Ⅱ. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection[J]. J Immunol,2004,172(4):2137-2146. |
[8] | EWAISHA R,GAWRYLETZ C D,ANDERSON K S.Crucial considerations for pipelines to validate circulating biomarkers for breast cancer[J]. Expert Rev Proteomics,2016,13(2):201-211. |
[9] | KLINKE D J znd,KULKARNI Y M,WU Y,et al. Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models[J]. Biotechnol Bioeng,2014,111(9):1853-1863. |
[10] | MENG Y,SUN J,WANG X,et al.Exosomes:a promising avenue for the diagnosis of breast cancer[J]. Technol Cancer Res Treat,2019,18:1533033818821421. |
[11] | TYTELL M,LASEK R J,GAINER H.Axonal maintenance,glia,exosomes,and heat shock proteins[J]. F1000Res,2016,5(F1000 Faculty Rev):205. |
[12] | SANTOS J C,LIMA N D S,SARIAN L O,et al. Exosome-mediated breast cancer chemoresistance via miR-155 transfer[J]. Sci Rep,2018,8(1):829. |
[13] | 陈丽娥,谢谢,王识华. 外泌体在乳腺癌病理诊断中的应用进展[J]. 医学综述,2020,26(14):2803-2806. |
[14] | 罗娇,周莉. 外泌体在乳腺癌脑转移诊断和治疗中的研究进展[J]. 肿瘤,2020,40(5):361-370. |
[15] | GAO X,LI S,DING F,et al.Rapid detection of exosomal micrornas using virus-mimicking fusogenic vesicles[J]. Angew Chem Int Ed Engl,2019,58(26):8719-8723. |
[16] | ZHANG C,JI Q,YANG Y,et al.Exosome:function and role in cancer metastasis and drug resistance[J]. Technol Cancer Res Treat,2018,17:1533033818763450. |
[17] | MASHOURI L,YOUSEFI H,AREF A R,et al.Exosomes:composition,biogenesis,and mechanisms in cancer metastasis and drug resistance[J]. Mol Cancer,2019,18(1):75. |
[18] | IM E J,LEE C H,MOON P G,et al.Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A[J]. Nat Commun,2019,10(1):1387. |
[19] | XIA X,WANG X,ZHANG S,et al.miR-31 shuttled by halofuginone-induced exosomes suppresses MFC-7 cell proliferation by modulating the HDAC2/cell cycle signaling axis[J]. J Cell Physiol,2019,234(10):18970-18984. |
[20] | WEI Y,LI M,CUI S,et al.Shikonin inhibits the proliferation of human breast cancer cells by reducing tumor-derived exosomes[J]. Molecules,2016,21(6):777. |
[21] | SHTAM T A,KOVALEV R A,VARFOLOMEEVA E Y,et al.Exosomes are natural carriers of exogenous siRNA to human cells in vitro[J]. Cell Commun Signal,2013,11:88. |
[22] | KIM M S,HANEY M J,ZHAO Y,et al.Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells[J]. Nanomedicine,2016,12(3):655-664. |
[23] | SATO Y T,UMEZAKI K,SAWADA S,et al.Engineering hybrid exosomes by membrane fusion with liposomes[J]. Sci Rep,2016,6:21933. |
[24] | FUHRMANN G,SERIO A,MAZO M,et al.Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins[J]. J Control Release,2015,205:35-44. |
[25] | MILANO G,BIEMMI V,LAZZARINI E,et al.Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity[J]. Cardiovasc Res,2020,116(2):383-392. |
[26] | KALIMUTHU S,GANGADARAN P,RAJENDRAN R L,et al.A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy[J]. Front Pharmacol,2018,9:1116. |
[27] | LIMONI S K,MOGHADAM M F,MOAZZENI S M,et al.Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells[J]. Appl Biochem Biotechnol,2019,187(1):352-364. |
[28] | ALVAREZ-ERVITI L,SEOW Y,YIN H,et al.Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes[J]. Nat Biotechnol,2011,29(4):341-345. |
[29] | LIANG G,ZHU Y,ALI D J,et al.Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer[J]. J Nanobiotechnology,2020,18(1):10. |
[30] | YU M,GAI C,LI Z,et al.Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells[J]. Cancer Sci,2019,110(10):3173-3182. |
[31] | XIONG F,LING X,CHEN X,et al.Pursuing specific chemotherapy of orthotopic breast cancer with lung metastasis from docking nanoparticles driven by bioinspired exosomes[J]. Nano Lett,2019,19(5):3256-3266. |
[32] | LI S,WU Y,DING F,et al.Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer[J]. Nanoscale,2020,12(19):10854-10862. |
[33] | ZUO B,QI H,LU Z,et al.Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice[J]. Nat Commun,2020,11(1):1790. |
[34] | GAO X,RAN N,DONG X,et al. Anchor peptide captures,targets,and loads exosomes of diverse origins for diagnostics and therapy[J]. Sci Transl Med,2018,10(444):eaat0195. |
[35] | SHI X,CHENG Q,HOU T,et al.Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy[J]. Mol Ther,2020,28(2):536-547. |
[1] | WANG Rong, XING Lianxiang, HUANG Keliang, LI Xin. MiR-374 promoting proliferation and invasion of breast cancer cells by targeting and down-regulating TRIM35 [J]. Laboratory Medicine, 2023, 38(9): 812-817. |
[2] | CHEN Wenju, ZHOU Yong, XU Jiajia, WANG Pan. Role of serum exosomal miR-23b-3p and miR-4429 in patients with hepatocellular carcinoma [J]. Laboratory Medicine, 2023, 38(7): 624-628. |
[3] | PAN Xin, LÜ Ying, LI Yang, LI Rongguo. Effects of miR-24-3p targeting CHD5 on migration,invasion and radiosensitivity of thyroid cancer cells [J]. Laboratory Medicine, 2023, 38(7): 640-646. |
[4] | WANG Tengfei, CHEN Shan, AN Hebing, ZHOU Lei. Expressions and roles of lncRNA CRNDE and miR-384 in peripheral blood of patients with acute leukemia [J]. Laboratory Medicine, 2023, 38(7): 686-691. |
[5] | ZHANG Ying, JING Lijuan, LI Li. Relationship between the expression of miR-138 in peripheral blood mononuclear cells of hepatitis B virus proliferation in carriers [J]. Laboratory Medicine, 2023, 38(6): 559-562. |
[6] | CHEN Chen, DUAN Qi, LU Jiatuan, ZHAI Xiaojian, WANG Zheng, ZHANG Hao, GUO Man. Expressions of ASH2L and HOXA2 in triple-negative breast cancer patients and their relationship with lymph node metastasis [J]. Laboratory Medicine, 2023, 38(6): 574-578. |
[7] | ZHANG Min, WANG Binyu, CHI Weiqun, LIU Yu. Research progress of exosomal non-coding RNA as biomarkers for disease diagnosis [J]. Laboratory Medicine, 2023, 38(6): 594-598. |
[8] | ZHAO Jing, WANG Pei, LU Dandan, QI Dandan, LI Xuan. Expression levels of serum miR-4443 and TRAF4 in patients with hemorrhagic stroke [J]. Laboratory Medicine, 2023, 38(5): 413-418. |
[9] | ZHANG Guoliang, LIU Yiwen, HE Yiqing, XU Jing, YANG Cuixia, GAO Feng, LIU Hua. Changes of serum HAS2 and CD44 levels in breast cancer patients and their clinical significance [J]. Laboratory Medicine, 2023, 38(5): 424-429. |
[10] | LIU Ruili, LI Lanjun, JIA Minlei, WANG Yihui, HAO Weina. Correlation between tumor miR-7-5p and NOVA2 levels and clinical prognosis in cancer tissues of patients with gastric cancer [J]. Laboratory Medicine, 2023, 38(4): 325-329. |
[11] | YUAN Shuang, FENG Lei, GUO Xiaofen, FU Xiaoling, XU Jing, LIU Hongyang. Relation of miR-433 in endometrial cancer tissues and its relationship with chemotherapy sensitivity [J]. Laboratory Medicine, 2023, 38(4): 337-341. |
[12] | LI Mu, GONG Dongliang, XU Liming, PENG Rong. Relationship of XPC rs2228000 polymorphisms and breast cancer [J]. Laboratory Medicine, 2023, 38(3): 235-239. |
[13] | CHEN Zhe, ZHANG Ling, LIU Jie, WANG Xia, ZHANG Bin, GAO Binghua. Relationship between serum miR-326 and chemotherapy sensitivity and prognosis in patients with treatment-related hematological malignancy [J]. Laboratory Medicine, 2023, 38(3): 251-256. |
[14] | LIU Chong, ZHANG Jing, LI Sheng, ZHAO Qi. Expressions and correlation of miR-335 and Fra-1 in breast cancer [J]. Laboratory Medicine, 2023, 38(2): 143-147. |
[15] | WU Jiong, HU Jiahua, SHI Meifang, LIU Tao, DAI Jie, LU Xinyi, ZOU Zheng. Research progress of biomarkers of prostate cancer [J]. Laboratory Medicine, 2023, 38(2): 190-195. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||